Acadia Healthcare Company, Inc. (ACHC) stands as a leader in the behavioral healthcare and rehabilitation therapy space, providing a full continuum of psychiatric and chemical dependency services for adults, children, and adolescents in various settings including inpatient psychiatric hospitals, outpatient clinics, and residential treatment centers.
Established in 2005 and headquartered in Franklin, Tennessee, the company is publicly traded on the NASDAQ under the symbol "ACHC." It operates a thriving network of several hundred treatment facilities across the United States and the United Kingdom, making it the largest standalone behavioral health services provider in the U.S.
ACHC’s mission is to create a world-class organization that sets the standard of excellence in the treatment of specialty behavioral health and addiction disorders. This is testament to the comprehensive, high-quality, and individualized healthcare they provide to those struggling with mental health or addiction issues.
The company’s approach is commendable. They partner with hospitals and clinics to manage their behavioral health services, or to set up new units. This not only increases the accessibility and affordability of such services, it also ensures that care is provided in a professional setting under the supervision of qualified medical personnel. With a patient-centric approach reflected in their commitment to service excellence, the company serves over 70,000 patients per day across its healthcare network.
Integrity, respect, and performance speak to the core values of Acadia. They are committed to upholding the highest standards of ethical and professional behavior, respecting the dignity and intrinsic worth of every individual, and dedicating themselves to delivering the highest level of service, supporting the tenets of accountability, teamwork, and best practices.
With the rise in mental health and substance abuse issues, the company continues to expand in response to the increasing demand for these services. Acadia has gained widespread recognition for its efforts in tackling mental health issues, earning widespread trust among patients, their families, and medical professionals.
Its continual growth and strong performance even amidst industry and economic challenges, makes ACHC a sturdy and solid player in the market. Their focus on having a positive social impact, whilst maintaining a solid bottom line, makes them not only a leader in the sector but a valuable investment for stakeholders. Furthermore, Acadia remains committed to ongoing investment in its services and infrastructure to better serve its patients and communities.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Leerink Partners has increased its target price for Acadia Healthcare Company, Inc. from $30 to $33. This update reflects an analyst's revised valuation for the healthcare company's stock.
Acadia Healthcare Co Inc (ACHC) saw a 3.5% gain, closing at $29.37, which is significantly below its GF Value™ estimate of $41.65, suggesting it is undervalued. Despite this, the company is currently unprofitable and cash-flow-negative, making a Price-to-Sales (P/S) approach more appropriate for valuation than earnings-based metrics. The GF Score™ of 69/100 indicates above-average performance, though financial strength and valuation remain weak points.
Acadia Healthcare Company (ACHC) is attracting investor attention ahead of its presentation at the Jefferies Healthcare Services and Technology Conference. Despite recent share price cooling, ACHC has seen significant year-to-date gains. Simply Wall St's analysis suggests the company is currently 15% undervalued, with a fair value of $32.21 against a last close of $27.38, emphasizing its growth and turnaround plans.
Acadia Healthcare Company, Inc. (ACHC) is implementing a turnaround strategy focused on maximizing returns from its existing facilities rather than pursuing aggressive growth. Following a period of challenges, Acadia has resolved billing disputes, strengthened compliance, and seen revenue growth in Q1 2026, leading to increased full-year adjusted EBITDA guidance. The company, which is the largest standalone behavioral health provider in the U.S., aims to convert past investments into improved profitability amid rising demand for mental health services.
A San Diego jury awarded $105 million to a former substance abuse counselor who alleged she was fired after reporting sexual harassment, a hidden camera, and patient safety concerns at a treatment facility. The verdict includes $35 million in compensatory damages and $70 million in punitive damages against San Diego Health Alliance, an indirect subsidiary of Acadia Healthcare. The company denies retaliation and plans to challenge the verdict through post-trial motions and appeals, noting that the punitive damages are substantial despite a 2-to-1 ratio with compensatory damages, which may be subject to constitutional review.